
Administered by the Korean Intellectual Property Office (KIPO) and regulated under the
revised South Korea Trademark Act (Act No.19809, 2023 Amendment) and the Unfair
Competition Prevention Act, South Korea enforces comprehensive statutory
protection for well-known trademarks, including independent anti-dilution provisions
that operate separately from likelihood-of-confusion standards. Unlike ordinary registered
marks limited to designated goods/services, well-known marks can block third-party
registration across dissimilar product categories to stop reputational erosion and unfair
free-riding. A landmark 2023 Supreme Court judgment established clear judicial criteria for
dilution claims, yet numerous foreign brands fail to meet strict evidentiary burdens during
invalidation trials due to incomplete localized market records. This case analyzes a cross-border
luxury brand’s failed dilution invalidation proceeding, unpacks judicial evaluation
standards, and delivers systematic compliance guidance for international enterprises targeting
South Korea’s retail and e-commerce market.
A European premium skincare giant owns a globally renowned word-and-device mark with
decades of cross-border marketing, yet it only launched limited online cross-border sales to
Korean consumers without establishing offline retail channels or localized Korean-language
advertising campaigns. In 2022, a local Korean medical aesthetics clinic filed a trademark
containing an almost identical core word element under Class 44 medical beauty services, goods
entirely dissimilar to the client’s Class 3 cosmetics. The European brand filed an invalidation
trial with the Korean Intellectual Property Trial and Appeal Board (IPTAB) under the anti-
dilution clause of the Trademark Act, arguing the local mark would dilute the distinctiveness
and prestige of its well-known brand. During the hearing, IPTAB dismissed the invalidation
petition for two decisive reasons. First, the applicant submitted only overseas sales data,
international magazine coverage and non-Korean social media promotion records, lacking
sufficient localized Korean market reputation evidence such as domestic sales invoices, Korean
media interviews, offline pop-up event footage or Korean consumer survey reports. Second,
the brand could not prove widespread recognition among ordinary Korean consumers, a
mandatory threshold to qualify for cross-class anti-dilution protection. The clinic retained full
trademark rights, launching mass marketing that confused Korean shoppers and diluted the
luxury brand’s premium market positioning. The foreign enterprise incurred costly rebranding
and additional trademark filing expenses to mitigate market losses.
South Korea’s independent well-known trademark anti-dilution regime delivers
powerful cross-category brand protection for internationally famous enterprises, yet its heavy
emphasis on localized domestic market evidence creates high compliance barriers for brands
relying solely on overseas remote sales. This IPTAB invalidation failure fully demonstrates that
global brand prestige cannot substitute verifiable Korean consumer recognition records
when pursuing dilution-based trademark cancellation. For cross-border consumer brands
expanding into South Korea, proactive localized marketing, standardized domestic evidence
archiving, and pre-emptive multi-class trademark filing are indispensable measures to block
reputational dilution, combat bad-faith squatting, and preserve premium brand value within
Korea’s competitive commercial landscape.
Hyperlink List:
● IPcrossark:
IPcrossark—Reliable IP Registration Platform | Trademark, Patent & Copyright Help
● KIPRIS Official Trademark Search Database (KIPO’s free retrieval portal):
https://engdtj.kipris.or.kr/engdtj/searchLogina.do?method=loginTM
● WIPO WIPOLEX Full Text of South Korea 2023 Revised Trademark Act (English)